Israeli Teva ((TEVA.TA)) Q2 net/ADR Rises On Year
July 25, 2001 00:25:22 (ET)
JERUSALEM, July 25 (Reuters) - Israeli generic drugmaker Teva Pharmaceutical Industries (TEVA,Trade) reported the following results on Wednesday. (in thousands of dollars except EPS)
Q2 01 Q2 00 6-MTH 01 6-MTH 00
Sales 513,590 443,997 1,004,518 781,331 Operating Profit 86,850 33,142 165,754 89,140 Net Profit 64,448 10,074 119,200 45,150 Earnings per ADR 0.47 0.08 0.87 0.35
Note: Net income and earnings per ADR figures for 2000 include a one-time charge of $35.7 million for research and development. Excluding the charge, net income for 2000 was $80.8 million and earnings per ADR was $0.63.
© Copyright 2001 Reuters. Click Here for Limitations and Restrictions on Use. |
